Cidara/Merck Phase 1 trial tests MK-1406 with Fluzone HD vaccine, recruitingNov 4Trial updateCidara Therapeutics, Incfluzone
Cidara's CD388 Phase 3 ANCHOR trial for flu prevention is recruiting, enrollment up to 10,000Oct 15Trial updateCidara Therapeutics, IncMerck & Co., Inc.
Merck registers Phase 3 ovarian cancer trial, plus Phase 1 study of MK-1406 in healthy adultsAug 3Weekly roundup, 2 itemsDaiichi SankyoMerck & Co., Inc.
Sign inSign in